Point72 Hong Kong’s Regeneron Pharmaceuticals REGN Stock Holding History

Point72 Hong Kong’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,300	Closed	-$2.96M	–	1341
2022 Q3	$2.96M	Buy	4,300 +2,300	+115%	+$1.45M	0.1%	244
2022 Q2	$1.18M	Sell	2,000 -300	-13%	-$195K	0.04%	480
2022 Q1	$1.61M	Sell	2,300 -2,900	-56%	-$1.83M	0.06%	381
2021 Q4	$3.28M	Hold	5,200	–	–	0.11%	198
2021 Q3	$3.15M	Buy	5,200 +100	+2%	+$62.1K	0.1%	261
2021 Q2	$2.85M	Buy	5,100 +4,600	+920%	+$2.33M	0.09%	289
2021 Q1	$237K	Buy	+500	New	+$243K	0.01%	1017

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Hong Kong's REGN Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2025: 11,958 shares worth $6.72M. The stake represents 0.31% of the portfolio and ranks #63 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in REGN as recently as Q4 2023.

Point72 Hong Kong first reported a position in REGN in Q4 2014 and has held it in 16 quarters since. The position peaked at $7.19M in Q4 2023. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

Point72 Hong Kong held 11,958 shares of Regeneron Pharmaceuticals worth $6.72M as of Q3 2025.
Regeneron Pharmaceuticals was a new Point72 Hong Kong position in Q3 2025.
Regeneron Pharmaceuticals made up 0.31% of Point72 Hong Kong's portfolio in Q3 2025, its #63 holding.
Point72 Hong Kong first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 16 quarters since.
Point72 Hong Kong's Regeneron Pharmaceuticals position peaked at $7.19M in Q4 2023.
1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.